Алон!
На Ваше бравирование «сертификатом», которое дает право обо всем и обо всех высокомерно, порой нецензурно судить – у меня иронии не хватает.
То, что Вы когда-то выучили и пересказали (о вирусах, иммунитете), то, что другие открыли, изучили и Вам на пальцах, попроще, через учебники рассказали, ещё не обозначает, что все остальные дилетанты. В частности, если Зайцев и дилетант (что, несомненно) в тех или иных вопросах - судить то об этом не Вам.
Что касается экспериментов над людьми. Вы, кажется, уже садились в лужу.
http://forums.rusmedserv.com/showpos...&postcount=155
А тут, вах, оказываются уже давно идут «эксперименты» над несчастными израильскими детьми, типа
Pediatrics, 2005 Jan, 115(1), 5 - 9
Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents; Weizman Z et al.; OBJECTIVE: To investigate the effect of 2 different species of probiotics in preventing infections in infants attending child care centers . METHODS: A double-blind, placebo-controlled, randomized trial was conducted from December 1, 2000, to September 30, 2002, at 14 child care centers in the Beer-Sheva area of Israel in healthy term infants 4 to 10 months old . Infants were assigned randomly to formula supplemented with Bifidobacterium lactis (BB-12), Lactobacillus reuteri (American Type Culture Collection 55730), or no probiotics . Duration of feeding, including follow-up, for each participant was 12 weeks . All infants were fed only the assigned formula and were not breastfed due to parental decision before recruitment to the study . Probiotic or prebiotic food products or supplements were not allowed . Main outcome measures were number of days and number of episodes with fever (>38 degrees C) and number of days and number of episodes with diarrhea or respiratory illness . RESULTS: Participants (n = 201) were similar regarding gestational age, birth weight, gender, and previous breastfeeding . The controls (n = 60), compared with those fed B lactis (n = 73) or L reuteri (n = 68), had significantly more febrile episodes (mean {95% confidence interval}: 0.41 {0.28-0.54} vs 0.27 {0.17-0.37} vs 0.11 {0.04-0.18}, respectively) . The controls also had more diarrhea episodes (0.31 {0.22-0.40} vs 0.13 {0.05-0.21} vs 0.02 {0.01-0.05}, respectively) and episodes of longer duration (0.59 {0.34-0.84} vs 0.37 {0.08-0.66} vs 0.15 {0.12-0.18} days, respectively) . The L reuteri group, compared with BB-12 or controls, had a significant decrease of number of days with fever, clinic visits, child care absences, and antibiotic prescriptions . Rate and duration of respiratory illnesses did not differ significantly between groups . CONCLUSIONS: Child care infants fed a formula supplemented with L reuteri or B lactis had fewer and shorter episodes of diarrhea, with no effect on respiratory illnesses . These effects were more prominent with L reuteri, which was also the only supplement to improve additional morbidity parameters.